Unmodified phosphodiester antisense oligodeoxynucleotides to the BCR-ABL junction do not suppress Philadelphia-positive clonogenic cells.
Identifieur interne : 002701 ( PubMed/Checkpoint ); précédent : 002700; suivant : 002702Unmodified phosphodiester antisense oligodeoxynucleotides to the BCR-ABL junction do not suppress Philadelphia-positive clonogenic cells.
Auteurs : A. K Bisch [Allemagne] ; L. Pérènyi ; U. Seay ; J. Lohmeyer ; H. PralleSource :
- Acta haematologica [ 0001-5792 ] ; 1994.
Descripteurs français
- KwdFr :
- ARN tumoral (génétique), Amorces ADN (), Cellules cancéreuses en culture, Clones cellulaires, Données de séquences moléculaires, Humains, Hématopoïèse (), Leucémie myéloïde chronique BCR-ABL positive (), Leucémie myéloïde chronique BCR-ABL positive (anatomopathologie), Oligonucléotides antisens (), Protéines de fusion bcr-abl (génétique), Séquence nucléotidique, Techniques in vitro.
- MESH :
- anatomopathologie : Leucémie myéloïde chronique BCR-ABL positive.
- génétique : ARN tumoral, Protéines de fusion bcr-abl.
- Amorces ADN, Cellules cancéreuses en culture, Clones cellulaires, Données de séquences moléculaires, Humains, Hématopoïèse, Leucémie myéloïde chronique BCR-ABL positive, Oligonucléotides antisens, Séquence nucléotidique, Techniques in vitro.
English descriptors
- KwdEn :
- Base Sequence, Clone Cells, DNA Primers (chemistry), Fusion Proteins, bcr-abl (genetics), Hematopoiesis (drug effects), Humans, In Vitro Techniques, Leukemia, Myelogenous, Chronic, BCR-ABL Positive (pathology), Leukemia, Myelogenous, Chronic, BCR-ABL Positive (therapy), Molecular Sequence Data, Oligonucleotides, Antisense (chemistry), RNA, Neoplasm (genetics), Tumor Cells, Cultured.
- MESH :
- chemical , chemistry : DNA Primers, Oligonucleotides, Antisense.
- chemical , genetics : Fusion Proteins, bcr-abl, RNA, Neoplasm.
- drug effects : Hematopoiesis.
- pathology : Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
- therapy : Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
- Base Sequence, Clone Cells, Humans, In Vitro Techniques, Molecular Sequence Data, Tumor Cells, Cultured.
Abstract
The BCR-ABL fusion gene is directly involved in the pathogenesis of chronic myeloid leukemia (CML). Specific inhibition of the BCR-ABL gene expression with antisense oligodeoxynucleotides has been shown to have profound effects on cell growth in vitro. We examined antisense phosphodiester oligonucleotides (16-mers at a concentration of 60 micrograms/ml) spanning the two possible junction sites K28 (b3a2) and L6 (b2a2) in a clonogenic assay. Single colonies from 9 patients with CML and from patients with normal bone marrow were screened for BCR-ABL expression with a new 'single-tube nested PCR' method. There was a marked reduction in colony number in the CML group and a lesser growth inhibition in the control group. The number and percentage of BCR-ABL-positive colonies, however, was not reduced in the CML group. This indicates a nonspecific growth inhibition only.
DOI: 10.1159/000204219
PubMed: 7701917
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:7701917Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Unmodified phosphodiester antisense oligodeoxynucleotides to the BCR-ABL junction do not suppress Philadelphia-positive clonogenic cells.</title>
<author><name sortKey="K Bisch, A" sort="K Bisch, A" uniqKey="K Bisch A" first="A" last="K Bisch">A. K Bisch</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Hematology and Oncology, Justus Liebig University, Giessen, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Hematology and Oncology, Justus Liebig University, Giessen</wicri:regionArea>
<wicri:noRegion>Giessen</wicri:noRegion>
<wicri:noRegion>Giessen</wicri:noRegion>
<wicri:noRegion>Giessen</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Perenyi, L" sort="Perenyi, L" uniqKey="Perenyi L" first="L" last="Pérènyi">L. Pérènyi</name>
</author>
<author><name sortKey="Seay, U" sort="Seay, U" uniqKey="Seay U" first="U" last="Seay">U. Seay</name>
</author>
<author><name sortKey="Lohmeyer, J" sort="Lohmeyer, J" uniqKey="Lohmeyer J" first="J" last="Lohmeyer">J. Lohmeyer</name>
</author>
<author><name sortKey="Pralle, H" sort="Pralle, H" uniqKey="Pralle H" first="H" last="Pralle">H. Pralle</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1994">1994</date>
<idno type="RBID">pubmed:7701917</idno>
<idno type="pmid">7701917</idno>
<idno type="doi">10.1159/000204219</idno>
<idno type="wicri:Area/PubMed/Corpus">002903</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002903</idno>
<idno type="wicri:Area/PubMed/Curation">002903</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002903</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002701</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002701</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Unmodified phosphodiester antisense oligodeoxynucleotides to the BCR-ABL junction do not suppress Philadelphia-positive clonogenic cells.</title>
<author><name sortKey="K Bisch, A" sort="K Bisch, A" uniqKey="K Bisch A" first="A" last="K Bisch">A. K Bisch</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Hematology and Oncology, Justus Liebig University, Giessen, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Hematology and Oncology, Justus Liebig University, Giessen</wicri:regionArea>
<wicri:noRegion>Giessen</wicri:noRegion>
<wicri:noRegion>Giessen</wicri:noRegion>
<wicri:noRegion>Giessen</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Perenyi, L" sort="Perenyi, L" uniqKey="Perenyi L" first="L" last="Pérènyi">L. Pérènyi</name>
</author>
<author><name sortKey="Seay, U" sort="Seay, U" uniqKey="Seay U" first="U" last="Seay">U. Seay</name>
</author>
<author><name sortKey="Lohmeyer, J" sort="Lohmeyer, J" uniqKey="Lohmeyer J" first="J" last="Lohmeyer">J. Lohmeyer</name>
</author>
<author><name sortKey="Pralle, H" sort="Pralle, H" uniqKey="Pralle H" first="H" last="Pralle">H. Pralle</name>
</author>
</analytic>
<series><title level="j">Acta haematologica</title>
<idno type="ISSN">0001-5792</idno>
<imprint><date when="1994" type="published">1994</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Base Sequence</term>
<term>Clone Cells</term>
<term>DNA Primers (chemistry)</term>
<term>Fusion Proteins, bcr-abl (genetics)</term>
<term>Hematopoiesis (drug effects)</term>
<term>Humans</term>
<term>In Vitro Techniques</term>
<term>Leukemia, Myelogenous, Chronic, BCR-ABL Positive (pathology)</term>
<term>Leukemia, Myelogenous, Chronic, BCR-ABL Positive (therapy)</term>
<term>Molecular Sequence Data</term>
<term>Oligonucleotides, Antisense (chemistry)</term>
<term>RNA, Neoplasm (genetics)</term>
<term>Tumor Cells, Cultured</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>ARN tumoral (génétique)</term>
<term>Amorces ADN ()</term>
<term>Cellules cancéreuses en culture</term>
<term>Clones cellulaires</term>
<term>Données de séquences moléculaires</term>
<term>Humains</term>
<term>Hématopoïèse ()</term>
<term>Leucémie myéloïde chronique BCR-ABL positive ()</term>
<term>Leucémie myéloïde chronique BCR-ABL positive (anatomopathologie)</term>
<term>Oligonucléotides antisens ()</term>
<term>Protéines de fusion bcr-abl (génétique)</term>
<term>Séquence nucléotidique</term>
<term>Techniques in vitro</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>DNA Primers</term>
<term>Oligonucleotides, Antisense</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Fusion Proteins, bcr-abl</term>
<term>RNA, Neoplasm</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Leucémie myéloïde chronique BCR-ABL positive</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Hematopoiesis</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>ARN tumoral</term>
<term>Protéines de fusion bcr-abl</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Leukemia, Myelogenous, Chronic, BCR-ABL Positive</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Leukemia, Myelogenous, Chronic, BCR-ABL Positive</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Base Sequence</term>
<term>Clone Cells</term>
<term>Humans</term>
<term>In Vitro Techniques</term>
<term>Molecular Sequence Data</term>
<term>Tumor Cells, Cultured</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Amorces ADN</term>
<term>Cellules cancéreuses en culture</term>
<term>Clones cellulaires</term>
<term>Données de séquences moléculaires</term>
<term>Humains</term>
<term>Hématopoïèse</term>
<term>Leucémie myéloïde chronique BCR-ABL positive</term>
<term>Oligonucléotides antisens</term>
<term>Séquence nucléotidique</term>
<term>Techniques in vitro</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The BCR-ABL fusion gene is directly involved in the pathogenesis of chronic myeloid leukemia (CML). Specific inhibition of the BCR-ABL gene expression with antisense oligodeoxynucleotides has been shown to have profound effects on cell growth in vitro. We examined antisense phosphodiester oligonucleotides (16-mers at a concentration of 60 micrograms/ml) spanning the two possible junction sites K28 (b3a2) and L6 (b2a2) in a clonogenic assay. Single colonies from 9 patients with CML and from patients with normal bone marrow were screened for BCR-ABL expression with a new 'single-tube nested PCR' method. There was a marked reduction in colony number in the CML group and a lesser growth inhibition in the control group. The number and percentage of BCR-ABL-positive colonies, however, was not reduced in the CML group. This indicates a nonspecific growth inhibition only.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">7701917</PMID>
<DateCompleted><Year>1995</Year>
<Month>05</Month>
<Day>02</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>02</Month>
<Day>16</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0001-5792</ISSN>
<JournalIssue CitedMedium="Print"><Volume>92</Volume>
<Issue>4</Issue>
<PubDate><Year>1994</Year>
</PubDate>
</JournalIssue>
<Title>Acta haematologica</Title>
<ISOAbbreviation>Acta Haematol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Unmodified phosphodiester antisense oligodeoxynucleotides to the BCR-ABL junction do not suppress Philadelphia-positive clonogenic cells.</ArticleTitle>
<Pagination><MedlinePgn>190-6</MedlinePgn>
</Pagination>
<Abstract><AbstractText>The BCR-ABL fusion gene is directly involved in the pathogenesis of chronic myeloid leukemia (CML). Specific inhibition of the BCR-ABL gene expression with antisense oligodeoxynucleotides has been shown to have profound effects on cell growth in vitro. We examined antisense phosphodiester oligonucleotides (16-mers at a concentration of 60 micrograms/ml) spanning the two possible junction sites K28 (b3a2) and L6 (b2a2) in a clonogenic assay. Single colonies from 9 patients with CML and from patients with normal bone marrow were screened for BCR-ABL expression with a new 'single-tube nested PCR' method. There was a marked reduction in colony number in the CML group and a lesser growth inhibition in the control group. The number and percentage of BCR-ABL-positive colonies, however, was not reduced in the CML group. This indicates a nonspecific growth inhibition only.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Käbisch</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Department of Hematology and Oncology, Justus Liebig University, Giessen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Pérènyi</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y"><LastName>Seay</LastName>
<ForeName>U</ForeName>
<Initials>U</Initials>
</Author>
<Author ValidYN="Y"><LastName>Lohmeyer</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Pralle</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>Switzerland</Country>
<MedlineTA>Acta Haematol</MedlineTA>
<NlmUniqueID>0141053</NlmUniqueID>
<ISSNLinking>0001-5792</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D017931">DNA Primers</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016376">Oligonucleotides, Antisense</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012334">RNA, Neoplasm</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 2.7.10.2</RegistryNumber>
<NameOfSubstance UI="D016044">Fusion Proteins, bcr-abl</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<GeneSymbolList><GeneSymbol>abl</GeneSymbol>
<GeneSymbol>bcr</GeneSymbol>
</GeneSymbolList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002999" MajorTopicYN="N">Clone Cells</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017931" MajorTopicYN="N">DNA Primers</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016044" MajorTopicYN="N">Fusion Proteins, bcr-abl</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006410" MajorTopicYN="N">Hematopoiesis</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015464" MajorTopicYN="N">Leukemia, Myelogenous, Chronic, BCR-ABL Positive</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016376" MajorTopicYN="N">Oligonucleotides, Antisense</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012334" MajorTopicYN="N">RNA, Neoplasm</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014407" MajorTopicYN="N">Tumor Cells, Cultured</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1994</Year>
<Month>1</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>1994</Year>
<Month>1</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>1994</Year>
<Month>1</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">7701917</ArticleId>
<ArticleId IdType="doi">10.1159/000204219</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Allemagne</li>
</country>
</list>
<tree><noCountry><name sortKey="Lohmeyer, J" sort="Lohmeyer, J" uniqKey="Lohmeyer J" first="J" last="Lohmeyer">J. Lohmeyer</name>
<name sortKey="Perenyi, L" sort="Perenyi, L" uniqKey="Perenyi L" first="L" last="Pérènyi">L. Pérènyi</name>
<name sortKey="Pralle, H" sort="Pralle, H" uniqKey="Pralle H" first="H" last="Pralle">H. Pralle</name>
<name sortKey="Seay, U" sort="Seay, U" uniqKey="Seay U" first="U" last="Seay">U. Seay</name>
</noCountry>
<country name="Allemagne"><noRegion><name sortKey="K Bisch, A" sort="K Bisch, A" uniqKey="K Bisch A" first="A" last="K Bisch">A. K Bisch</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002701 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002701 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= PubMed |étape= Checkpoint |type= RBID |clé= pubmed:7701917 |texte= Unmodified phosphodiester antisense oligodeoxynucleotides to the BCR-ABL junction do not suppress Philadelphia-positive clonogenic cells. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:7701917" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a MersV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |